Results 251 to 260 of about 160,452 (346)

Dengue. [PDF]

open access: yesCMAJ
Billick MJ, Bogoch II.
europepmc   +1 more source

Outcome and safety of multiple photodynamic therapy sessions in chronic central serous chorioretinopathy

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose This study evaluates the effectiveness and safety of multiple PDT sessions for cases of persistent and recurrent subretinal fluid (SRF) in chronic central serous chorioretinopathy (CSC). Methods This multicentre, retrospective cohort study included patients aged ≥18 years with chronic CSC who received at least two sessions of PDT at ...
Jennifer M. Chang‐Wolf   +7 more
wiley   +1 more source

Spontaneous Intestinal Perforation in Extremely Premature Infants Exposed to Early Low‐Dose Hydrocortisone

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To assess the occurrence of spontaneous intestinal perforation (SIP) in < 28 weeks' gestational age (GA) infants exposed to early low‐dose hydrocortisone (ELH) to reduce the risk of bronchopulmonary dysplasia (BPD). Additionally, the risk of SIP was assessed in infants exposed to early concomitant treatment with ibuprofen for persistent ...
Gilles Cambonie   +5 more
wiley   +1 more source

Time course of clinical signs and mortality in dogs with severe perioperative acute kidney injury: A scoping review

open access: yesAustralian Veterinary Journal, EarlyView.
Perioperative acute kidney injury (AKI) is a potential cause of anaesthetic mortality in dogs. The time delay between anaesthetic recovery, onset of clinical signs and any subsequent mortality may result in under‐recognition of this complication. This review aimed to explore the literature reporting dogs with severe AKI after general anaesthesia and ...
C.T. Quinn
wiley   +1 more source

Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) result from immune self‐tolerance loss, causing tissue damage. Standard treatments targeting late‐stage inflammation often have serious side effects. Artemisinin, known for its antimalarial properties, shows potential immunomodulatory effects.
Fanchao Zhou   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy